clinical trial · NCT07011485
A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.
PDFE Pharma Innovations FZCO·phase2·active not recruiting·n = 15
Alopecia, AndrogeneticBaldnessAndrogenetic Alopecia (AGA)Minoxidil 5% Topical SolutionPDFE-2304 Topical Solution
brief summary
This study will evaluate the safety and efficacy of PDFE-2304 compared with Minoxidil 5% in men with androgenic alopecia (AGA).
started
May 14, 2025
primary completion
Aug 14, 2025
completion
Sep 17, 2025
last updated
Jun 8, 2025
official title
A Triple-Blind, Randomized, Efficacy and Tolerability Comparison Study of PDFE-2304 Topical Solution Versus Minoxidil 5% Topical Solution for the Treatment of Androgenic Alopecia (AGA).
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol